Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s share price dropped 25.3% during trading on Friday . The stock traded as low as GBX 13 ($0.16) and last traded at GBX 13.45 ($0.17). Approximately 124,310 shares changed hands during trading, a decline of 66% from the average daily volume of 362,092 shares. The stock had previously closed at GBX 18 ($0.22).
Celadon Pharmaceuticals Stock Performance
The firm has a market cap of £9.15 million, a price-to-earnings ratio of -166.13 and a beta of -0.26. The stock’s fifty day moving average is GBX 17.46 and its two-hundred day moving average is GBX 30.39. The company has a debt-to-equity ratio of 194.82, a quick ratio of 6.97 and a current ratio of 1.92.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- What Are the FAANG Stocks and Are They Good Investments?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- The 3 Best Retail Stocks to Shop for in August
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- 3 Grocery Stocks That Are Proving They Are Still Essential
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
